Scinai Immunotherapeutics (SCNI) Receivables (2015 - 2026)
Scinai Immunotherapeutics' (SCNI) quarterly Receivables came in at $74000.0 in Q2 2026, down 46.76% year-over-year from $139000.0 in Q2 2025, and down 50.67% quarter-over-quarter from $150000.0 in Q1 2026.
Powered by 
Analysis
Scinai Immunotherapeutics (SCNI) Receivables (2015 - 2026) Analysis & Trends
Scinai Immunotherapeutics has disclosed Receivables across 11 years of filings, most recently posting $74000.0 for Q2 2026.
- In Q2 2026, Receivables fell 46.76% year-over-year to $74000.0; the TTM figure through Jun 2026 stood at $74000.0 (down 46.76% YoY), while the FY2025 annual figure was $160000.0, down 13.98% from the prior year.
- Receivables came in at $74000.0 for Q2 2026 at Scinai Immunotherapeutics, down from $150000.0 in the prior quarter.
- In the past five years, Receivables ranged from a high of $298000.0 in Q3 2022 to a low of $73000.0 in Q1 2022.
- Average Receivables over 4 years is $149800.0, with a median of $144500.0 recorded in 2025.
- Year-over-year, Receivables tumbled 93.22% in 2022 and advanced 16.81% in 2025.
- Over 4 years, Receivables stood at $298000.0 in 2022, then slumped by 37.58% to $186000.0 in 2024, then fell by 13.98% to $160000.0 in 2025, then plunged by 53.75% to $74000.0 in 2026.
- Per Business Quant data, the three most recent Receivables figures were $74000.0 in Q2 2026, $150000.0 in Q1 2026, and $160000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 10.23 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 5.90 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 2.13 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 6.57 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 1.93 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 160.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 912.74 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 1.89 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Scinai Immunotherapeutics | 1.52 Bn | 1.52 Bn | -1.25 Mn | 74,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 74,000.00 |
| Mar 31, 2026 | 150,000.00 |
| Dec 31, 2025 | 160,000.00 |
| Jun 30, 2025 | 139,000.00 |
| Dec 31, 2024 | 186,000.00 |
| Sep 30, 2024 | 120,000.00 |
| Jun 30, 2024 | 119,000.00 |
| Sep 30, 2022 | 298,000.00 |
| Jun 30, 2022 | 179,000.00 |
| Mar 31, 2022 | 73,000.00 |
| Dec 31, 2021 | 651,000.00 |
| Sep 30, 2021 | 442,000.00 |
| Jun 30, 2021 | 2.64 Mn |
| Mar 31, 2021 | 481,000.00 |
| Dec 31, 2020 | 1.20 Mn |
| Sep 30, 2020 | 851,000.00 |
| Jun 30, 2020 | 2.47 Mn |
| Mar 31, 2020 | 1.54 Mn |
| Dec 31, 2019 | 190,000.00 |
| Sep 30, 2019 | 542,000.00 |